Concepedia

J. Norfleet

JN

Statistics

Publications

6

Citations

969

H-Index

6

Active since

2009

Affiliations

Duke Medical Center(Current)

Duke University Hospital

Duke University

Pediatric Brain Tumor Foundation

Dana-Farber Cancer Institute

J. Norfleet is an author at Duke Medical Center specializing in oncology, medicine, and neuro-oncology.

Publications per year

2009–2012

6

Publications

6

Phase II trial of bevacizumab and erlotinib in patients with recurrent malignant glioma

Sith Sathornsumetee, Annick Desjardins, James J. Vredenburgh et al. · Neuro-Oncology · 2010 · 230 citations · Full text

, , +17

Phase 2 trial of erlotinib plus sirolimus in adults with recurrent glioblastoma

David A. Reardon, Annick Desjardins, James J. Vredenburgh et al. · Journal of Neuro-Oncology · 2009 · 229 citations

, , +14

Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study

David A. Reardon, Annick Desjardins, James J. Vredenburgh et al. · British Journal of Cancer · 2009 · 209 citations · Full text

, , +16

Bevacizumab therapy for adults with recurrent/progressive meningioma: a retrospective series

Emil Lou, Ashley Sumrall, Scott Turner et al. · Journal of Neuro-Oncology · 2012 · 195 citations · Full text

, , +7

Phase II study of Gleevec® plus hydroxyurea (HU) in adults with progressive or recurrent meningioma

David A. Reardon, Andrew D. Norden, Annick Desjardins et al. · Journal of Neuro-Oncology · 2011 · 92 citations · Full text

, , +7

1–5 of 6